Literature DB >> 27809750

Chaperoning the Cancer: The Proteostatic Functions of the Heat Shock Proteins in Cancer.

Sepideh Vahid, Daksh Thaper, Amina Zoubeidi1.   

Abstract

BACKGROUND: Protein homeostasis (proteostasis) is vital for the survival of cells in physiological and pathological conditions. Particularly, cancer cells are in constant state of cellular stress due to rapid proliferation and decreased quality control in proteosynthesis and therefore, are exceedingly dependent on the homeostasis pathways. Among the complex biological mechanisms regulating proteostasis are the highly conserved molecular chaperones, heat shock proteins (HSPs). HSPs assist cell survival by catalysing the proper folding of proteins, modulation of the apoptotic machinery and finally regulating the protein degradation machinery, providing either the stability or the degradation of selected proteins under stress conditions. Inevitably, HSPs are upregulated in malignancies and participate in different hallmarks of cancer, with indispensable roles in the onset and progression of the disease. Moreover, high levels of HSPs contribute to poor prognosis and treatment resistance in various cancers. Therefore these molecular chaperones present as attractive targets for anti-cancer therapy.
OBJECTIVE: This review describes how HSPs regulate different hallmarks of cancer and provides an overview on the most relevant patents which have recently appeared in the literature.
METHODS: The patents were extracted from Google Patents (2012-2016) while the clinical trial results were mined from www.clinicaltrial.gov. RESULTS AND
CONCLUSION: Review of literature shows that the proteostatic functions of HSPs can modify different hallmarks of cancer. Moreover, targeting HSPs (notably HSP27, HSP70 and HSP90) exhibited positive results in clinical trials so far. However, more studies should be designed to optimize the efficacy of mono or combination therapy in various malignancies. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Cancer therapeutics; HSP; chaperons; hallmarks of cancer; proteostasis

Mesh:

Substances:

Year:  2017        PMID: 27809750     DOI: 10.2174/1574892811666161102125252

Source DB:  PubMed          Journal:  Recent Pat Anticancer Drug Discov        ISSN: 1574-8928            Impact factor:   4.169


  7 in total

1.  The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.

Authors:  G R Tundo; D Sbardella; A M Santoro; A Coletta; F Oddone; G Grasso; D Milardi; P M Lacal; S Marini; R Purrello; G Graziani; M Coletta
Journal:  Pharmacol Ther       Date:  2020-05-19       Impact factor: 12.310

2.  Engineering docetaxel-loaded micelles for non-small cell lung cancer: a comparative study of microfluidic and bulk nanoparticle preparation.

Authors:  Yuchen Bao; Qinfang Deng; Yongyong Li; Songwen Zhou
Journal:  RSC Adv       Date:  2018-09-14       Impact factor: 4.036

3.  GALNT5 uaRNA promotes gastric cancer progression through its interaction with HSP90.

Authors:  Hui Guo; Lianmei Zhao; Bianhua Shi; Jiayu Bao; Dexian Zheng; Baoguo Zhou; Juan Shi
Journal:  Oncogene       Date:  2018-05-10       Impact factor: 9.867

4.  Functional redundancy of HSPA1, HSPA2 and other HSPA proteins in non-small cell lung carcinoma (NSCLC); an implication for NSCLC treatment.

Authors:  Damian Robert Sojka; Agnieszka Gogler-Pigłowska; Natalia Vydra; Alexander Jorge Cortez; Piotr Teodor Filipczak; Zdzisław Krawczyk; Dorota Scieglinska
Journal:  Sci Rep       Date:  2019-10-07       Impact factor: 4.379

5.  Complex Crystal Structure Determination and in vitro Anti-non-small Cell Lung Cancer Activity of Hsp90 N Inhibitor SNX-2112.

Authors:  Dong Zhao; Yi-Ming Xu; Lu-Qi Cao; Feng Yu; Huan Zhou; Wei Qin; Hui-Jin Li; Chun-Xia He; Lu Xing; Xin Zhou; Peng-Quan Li; Xin Jin; Yuan He; Jian-Hua He; Hui-Ling Cao
Journal:  Front Cell Dev Biol       Date:  2021-03-29

6.  Complex Crystal Structure Determination of Hsp90N-NVP-AUY922 and In Vitro Anti-NSCLC Activity of NVP-AUY922.

Authors:  Chun-Xia He; You Lv; Meng Guo; Huan Zhou; Wei Qin; Dong Zhao; Hui-Jin Li; Lu Xing; Xin Zhou; Peng-Quan Li; Feng Yu; Jian-Hua He; Hui-Ling Cao
Journal:  Front Oncol       Date:  2022-02-24       Impact factor: 6.244

7.  A Long Non-coding RNA Lnc712 Regulates Breast Cancer Cell Proliferation.

Authors:  Yue Cui; Chunxiao Lu; Zhiming Zhang; Aiqin Mao; Lei Feng; Li Fu; Feng Gu; Xin Ma; Dongxu He
Journal:  Int J Biol Sci       Date:  2020-01-01       Impact factor: 6.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.